Syner-G BioPharma Group & Sequoia Biotech Consulting have appointed Chris Erickson as Chief Operating Officer (COO).

Experience

With more than 25 years of industry experience leading pharmaceutical services firms, Erickson brings expertise in scaling global operations, enhancing commercial strategies, and driving customer-centric growth.

Most recently, he served as the Chief Commercial Officer at Cytel, where he played a pivotal role in the exponential expansion of its operations, consulting, and software businesses. During his tenure, he also contributed to the successful due diligence and integration of multiple acquisitions.

Prior to Cytel, Erickson served in roles of increasing responsibility at PAREXEL for more than two decades in both business and commercial leadership. In his last role, leading the Real-World Evidence Solution business globally, he was responsible for double digit growth in both revenue and profitability.

“I am honored to join Syner-G & Sequoia at such a pivotal time in its growth journey,” said Erickson. “The company’s commitment to innovation, customer success, and operational excellence aligns perfectly with my own values and experience. I look forward to working alongside this talented team to drive strategic initiatives and deliver outstanding solutions for our clients.”